UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$324M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$241M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$150M |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$142M |
| 5 |
UBS Group
UBS
|
+$140M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ETF
ACWI
|
+$630M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$608M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$368M |
| 4 |
Tesla
TSLA
|
+$339M |
| 5 |
Amazon
AMZN
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.88% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.52% |
| 4 | Consumer Discretionary | 4.99% |
| 5 | Industrials | 4.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8026
Great Elm Group
GEG
$69.9M
| $13K | ﹤0.01% |
6,746
+5,354
| +385% | +$11.1K |
|
8027
Goldman Sachs ActiveBeta Japan Equity ETF
GSJY
$86.4M
| $13K | ﹤0.01% |
475
-2
| -0.4% | -$59 |
|
8028
The Honest Company
HNST
$597M
| $13K | ﹤0.01% |
3,600
-2,863
| -44% | -$10.5K |
|
|
IAF
8029
abrdn Australia Equity Fund
IAF
$126M
| $13K | ﹤0.01% |
1,036
-221
| -18% | -$3.13K |
|
8030
iShares iBonds Dec 2031 Term Treasury ETF
IBTL
$649M
| $13K | ﹤0.01% |
625
-2,838
| -82% | -$61.6K |
|
8031
Intellicheck
IDN
$76.8M
| $13K | ﹤0.01% |
5,450
+5,368
| +6,546% | +$13.8K |
|
8032
iShares Core 10+ Year USD Bond ETF
ILTB
$594M
| $13K | ﹤0.01% |
259
-3,020
| -92% | -$167K |
|
|
IMOS
8033
ChipMOS TECHNOLOGIES
IMOS
$1.83B
| $13K | ﹤0.01% |
709
+635
| +858% | +$14.3K |
|
|
ITRM
8034
DELISTED
Iterum Therapeutics
ITRM
| $13K | ﹤0.01% |
+8,321
| New | +$25.3K |
|
8035
John Hancock Corporate Bond ETF
JHCB
$109M
| $13K | ﹤0.01% |
647
+432
| +201% | +$9.2K |
|
8036
Kamada
KMDA
$412M
| $13K | ﹤0.01% |
2,949
+509
| +21% | +$2.48K |
|
8037
Kiora Pharmaceuticals
KPRX
$11.3M
| $13K | ﹤0.01% |
238
+158
| +198% | +$12.3K |
|
8038
Knightscope
KSCP
$30.8M
| $13K | ﹤0.01% |
+110
| New | +$16K |
|
8039
Kaixin Holdings
KXIN
$9M
| – | – |
0
| – | – |
|
8040
PUT
Lazard
LAZ
$4.22B
| $13K | ﹤0.01% |
400
-331,000
| -100% | -$11.9M |
|
8041
Xtrackers S&P MidCap 400 ESG ETF
MIDE
$3.47M
| $13K | ﹤0.01% |
570
-377
| -40% | -$9.16K |
|
|
MRM
8042
MEDIROM Healthcare Technologies
MRM
$7.24M
| $13K | ﹤0.01% |
2,112
+7
| +0.3% | +$44 |
|
8043
Emerson Radio
MSN
$7.71M
| $13K | ﹤0.01% |
23,121
+21,018
| +999% | +$13.8K |
|
|
FEED
8044
ENvue Medical Inc
FEED
$3.67M
| $13K | ﹤0.01% |
+13
| New | +$17K |
|
8045
Nocera
NCRA
$3.18M
| $13K | ﹤0.01% |
+309
| New | +$18.9K |
|
8046
NextNav
NN
$2.05B
| $13K | ﹤0.01% |
4,980
+3,179
| +177% | +$9.21K |
|
8047
Nuvation Bio
NUVB
$2.13B
| $13K | ﹤0.01% |
5,620
+3,024
| +116% | +$8.63K |
|
8048
Oriental Culture Holding
OCG
$3.2M
| $13K | ﹤0.01% |
5
+3
| +150% | +$20K |
|
8049
Orion Group Holdings
ORN
$410M
| $13K | ﹤0.01% |
5,000
-500
| -9% | -$1.31K |
|
8050
Patriot National Bancorp
PNBK
$134M
| $13K | ﹤0.01% |
1,234
+99
| +9% | +$1.18K |
|
Similar funds
UBS Group's Q3 2022 Portfolio in Review
As of Q3 2022, UBS Group held 11,885 positions worth $228B, down 6.3% from $244B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group's Q3 2022 filing shows 1,175 new, 4,825 increased, 3,846 reduced and 1,024 closed positions. Its largest new stake was Fairlead Tactical Sector ETF: 824,803 shares worth $18.4M. The largest sale was iShares MSCI ACWI ETF, an estimated $630M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q3 2022 buy was Fairlead Tactical Sector ETF: 824,803 shares worth $18.4M.
- UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $324M increase.
- UBS Group's biggest Q3 2022 reduction was iShares MSCI ACWI ETF, cutting an estimated $630M.
- UBS Group fully exited CMC Materials, Inc. Common Stock in Q3 2022, selling an estimated $111M.
- UBS Group's ten largest holdings make up 14% of its $228B portfolio in Q3 2022.
- UBS Group opened 1,175 new positions and closed 1,024 in Q3 2022.
- UBS Group's portfolio value fell 6.3% quarter-over-quarter to $228B.
Based on UBS Group's 13F filing for Q3 2022, filed 10 Nov 2022.